Zhu, J., Lu, Z., Wu, J., Guo, X., Qiao, J., Wang, C., Zhang, C., Zhang, J., Jiao, D., Li, J., Xie, T., Wang, L., Wang, J., Sun, Y., Zhao, Y., Liu, Z. (2026). Neoadjuvant dalpiciclib combined with letrozole and dual HER2 blockade in HR+/HER2+ breast cancer: First-stage results of the HELEN HER2 017 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.1054